CompletedPhase 1NCT01639612

Pilot Study of Bone Marrow/Stem Cells in Grade IV Malignant Glioma

Studying Glial tumor

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Henry Friedman
Principal Investigator
Annick Desjardins, MD, MD
Duke University
Intervention
ALD-451(biological)
Enrollment
11 target
Eligibility
18 years · All sexes
Timeline
20122016

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01639612 on ClinicalTrials.gov

Other trials for Glial tumor

Additional recruiting or active studies for the same condition.

See all trials for Glial tumor

← Back to all trials